University of Gothenburg logotyp, link to start page

Sahlgrenska Academy Institute of Neuroscience and Physiology

Sitemap

To content Read more about how we use cookies on gu.se

Bob Olsson

Researcher

Overview Publications UNDEFINED UNDEFINED UNDEFINED

Bob Olsson
Researcher
MD, PhD
bob.olsson@neuro.gu.se
+46 31-343 0025

Postal Address: V-huset, Mölndals sjukhus, 43180 Mölndal
Visiting Address: V-huset, Mölndals sjukhus , 43180 Mölndal

Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology (More Information)
Blå stråket 15, vån 3 SU/Sahlgrenska
413 45 Göteborg
031-342 10 00
Visiting Address: Blå stråket 15, vån 3 SU/Sahlgrenska , 413 45 Göteborg

Latest publications

NFL is a marker of treatment response in children with SMA treated with nusinersen
Bob Olsson, L. Alberg, Nicholas C Cullen, Eva Michael, Lisa Wahlgren et al.
Journal of Neurology, Journal article 2019
Journal article

Read the full text
on a web page

Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseases
Radu Constantinescu, Ubah Mahamud, Clara Constantinescu, Barbro Eriksson, Lenka Novakova et al.
Acta Neurologica Scandinavica, Journal article 2019
Journal article

Read the full text
on a web page

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology.
Erik Portelius, Bob Olsson, Kina Höglund, Nicholas C Cullen, Hlin Kvartsberg et al.
Acta neuropathologica, Journal article 2018
Journal article

Read the full text
on a web page

Preclinical effects of APOE epsilon 4 on cerebrospinal fluid A beta 42 concentrations
Ronald Lautner, P. S. Insel, Tobias Skillbäck, Bob Olsson, Mikael Landén et al.
Alzheimers Research & Therapy, Journal article 2017
Journal article

Read the full text
on a web page

The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials
Bob Olsson, J. M. Schott, Kaj Blennow, Henrik Zetterberg
Expert Review of Neurotherapeutics, Journal article 2017
Journal article

Read the full text
on a web page

Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis
J. Mellergard, A. Tisell, I. Blystad, A. Gronqvist, Kaj Blennow et al.
European Journal of Neurology, Journal article 2017
Journal article

Read the full text
on a web page

Normalised immune expression in remission of paediatric ITP
Margareta Jernås, Frida Strömberg Celind, Intawat Nookaew, Karin Mellgren, Hans Wadenvik et al.
Thrombosis and Haemostasis, Journal article 2016
Journal article

Read the full text
on a web page

The clinical value of fluid biomarkers for dementia diagnosis - Authors' reply.
Bob Olsson, Kaj Blennow, Henrik Zetterberg
The Lancet. Neurology, Editorial letter 2016
Editorial letter

Read the full text
on a web page

Adenine-induced chronic renal failure in rats decreases aortic relaxation rate and alters expression of proteins involved in vascular smooth muscle calcium handling.
Lisa Nguy, Emman Shubbar, Margareta Jernås, Intawat Nookaew, Jaana Lundgren et al.
Acta physiologica (Oxford, England), Journal article 2016
Journal article

Read the full text
on a web page

Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis
M. A. Mañé-Martínez, Bob Olsson, L. Bau, E. Matas, Á Cobo-Calvo et al.
Journal of Neuroimmunology, Journal article 2016
Journal article

Read the full text
on a web page

Showing 1 - 10 of 83

2019

NFL is a marker of treatment response in children with SMA treated with nusinersen
Bob Olsson, L. Alberg, Nicholas C Cullen, Eva Michael, Lisa Wahlgren et al.
Journal of Neurology, Journal article 2019
Journal article

Read the full text
on a web page

Cerebrospinal fluid biomarkers in patients with neurological symptoms but without neurological diseases
Radu Constantinescu, Ubah Mahamud, Clara Constantinescu, Barbro Eriksson, Lenka Novakova et al.
Acta Neurologica Scandinavica, Journal article 2019
Journal article

Read the full text
on a web page

2018

Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology.
Erik Portelius, Bob Olsson, Kina Höglund, Nicholas C Cullen, Hlin Kvartsberg et al.
Acta neuropathologica, Journal article 2018
Journal article

Read the full text
on a web page

2017

Preclinical effects of APOE epsilon 4 on cerebrospinal fluid A beta 42 concentrations
Ronald Lautner, P. S. Insel, Tobias Skillbäck, Bob Olsson, Mikael Landén et al.
Alzheimers Research & Therapy, Journal article 2017
Journal article

Read the full text
on a web page

The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials
Bob Olsson, J. M. Schott, Kaj Blennow, Henrik Zetterberg
Expert Review of Neurotherapeutics, Journal article 2017
Journal article

Read the full text
on a web page

Cerebrospinal fluid levels of neurofilament and tau correlate with brain atrophy in natalizumab-treated multiple sclerosis
J. Mellergard, A. Tisell, I. Blystad, A. Gronqvist, Kaj Blennow et al.
European Journal of Neurology, Journal article 2017
Journal article

Read the full text
on a web page

2016

Normalised immune expression in remission of paediatric ITP
Margareta Jernås, Frida Strömberg Celind, Intawat Nookaew, Karin Mellgren, Hans Wadenvik et al.
Thrombosis and Haemostasis, Journal article 2016
Journal article

Read the full text
on a web page

The clinical value of fluid biomarkers for dementia diagnosis - Authors' reply.
Bob Olsson, Kaj Blennow, Henrik Zetterberg
The Lancet. Neurology, Editorial letter 2016
Editorial letter

Read the full text
on a web page

Adenine-induced chronic renal failure in rats decreases aortic relaxation rate and alters expression of proteins involved in vascular smooth muscle calcium handling.
Lisa Nguy, Emman Shubbar, Margareta Jernås, Intawat Nookaew, Jaana Lundgren et al.
Acta physiologica (Oxford, England), Journal article 2016
Journal article

Read the full text
on a web page

Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis
M. A. Mañé-Martínez, Bob Olsson, L. Bau, E. Matas, Á Cobo-Calvo et al.
Journal of Neuroimmunology, Journal article 2016
Journal article

Read the full text
on a web page

Showing 1 - 10 of 83

1
2
3
4
5
6
7
8
9
Next

Page Manager: Webbredaktör
Last update: 9/1/2015 10:55 AM

Tell a friend about this page
Print version

Page Manager: Webbredaktör|Last update: 9/1/2015

Share:

© University of Gothenburg, Sweden
Box 100, S-405 30 Gothenburg
Phone +46 31-786 0000, Kontakt

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies. What are cookies?